Workflow Orchestration for Monoclonal Antibody Clinical Trial Pre-screening

Data for monoclonal antibody clinical trial pre-screening primarily originates from public clinical trial registries (e.g., ClinicalTrials.gov, WHO

Data Characteristics for This Category

Data for monoclonal antibody clinical trial pre-screening primarily originates from public clinical trial registries (e.g., ClinicalTrials.gov, WHO ICTRP), patent databases, biopharmaceutical company annual reports, academic papers, and internal research and development reports. Data update frequencies vary. Clinical trial registration information typically updates in real-time. Patent data and academic papers have monthly or quarterly update cycles. Document structures are diverse, including structured database records, semi-structured XML or JSON files, and unstructured PDF reports. Key fields include target information, mechanism of action, indications, routes of administration, dosage, trial phase, inclusion criteria, exclusion criteria, adverse events, and biomarkers. Units involve dosage (e.g., mg/kg, mg), time (e.g., weeks, months), and concentration (e.g., nM, μg/mL). Unit inconsistencies exist across different sources.

Constraints Imposed by These Characteristics on "Workflow Orchestration"

The heterogeneous nature of monoclonal antibody data requires robust data cleaning and standardization capabilities within the workflow. For example, dosage units from different sources must be uniformly converted to mg/kg or mg to ensure analytical accuracy. Clinical trial inclusion and exclusion criteria are often described in unstructured text. This requires a Natural Language Processing (NLP) module for entity recognition and relationship extraction to convert them into comparable structured conditions. Varying data update frequencies mean the workflow must support incremental updates and periodic full synchronization, avoiding redundant processing. The complexity of target information and mechanisms of action requires the workflow to flexibly integrate external knowledge graphs or ontologies for semantic enhancement. For sensitive data like internal R&D reports, workflow permission control and data anonymization features are crucial. While the data volume is large, the structural information of monoclonal antibodies is relatively stable, allowing the use of pre-computed feature vectors to accelerate retrieval.

Configuration Settings

Configuration ItemRecommended ValueRationale
Chunk Size500–800 charactersBalances context completeness and retrieval efficiency, avoiding dilution of key information by overly long texts.
Recall CountTop 10–15 itemsEnsures coverage of potentially relevant information while reducing computational load for subsequent re-ranking modules.
Similarity Threshold0.75–0.85Filters out low-relevance document chunks, improving the accuracy of pre-screening results and reducing false positives.
Rerank Return CountTop 5 itemsSelects the most relevant document chunks for model analysis, reducing interference from irrelevant information.
PARSE_FILE_TIMEOUT_SECONDS600 secondsAccommodates potential parsing time for large PDF clinical reports and patent documents, preventing timeouts.
maxContext32000 tokensMeets the context requirements for lengthy clinical trial descriptions and complex inclusion/exclusion criteria.

Three Common Mistakes

  1. Error: Workflow fails midway with Cannot convert undefined or null to object. Reason: Upstream data cleaning module failed to correctly handle null or missing fields, causing downstream components to receive null or undefined objects.
  2. Error: AI conversation output is unexpected, containing unprocessed raw data or having a disorganized format. Reason: The AI model directly outputs to the chat interface without post-processing by text concatenation or formatting components, leading to poor information presentation.
  3. Error: Clinical trial pre-screening results contain a large number of irrelevant or low-relevance entries. Reason: The vector database's Similarity Threshold is set too low, or the text chunking strategy is inappropriate, leading to the recall of too much noisy information.

How to Confirm Proper Configuration

  • Verify unit consistency for key fields, ensuring all numerical fields like dosage and time are converted to standard units.
  • Check the accuracy of NLP module entity recognition for inclusion/exclusion criteria. Randomly sample 20 standard texts and manually verify entity extraction results.
  • Evaluate the end-to-end response time of the workflow by simulating different query scenarios, ensuring it is within an acceptable range.
  • Compare the overlap between pre-screening results and expert manual judgment, then adjust Similarity Threshold and Recall Count based on feedback.

Note: The values provided are common starting points. Measure them against your own samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.